Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is ¥195,103.78, with a 24-hour trading volume of ¥0. The asset's market cap is ¥173.98T, after moving -0.17% in the last day.
Tokenized Eli Lilly And Co is trading at ¥195,533.87, with a tokenized market cap of ¥7.59B and a 24-hour trading volume of ¥333.34M. The tokenized asset has moved 0.60% in the past 24 hours.